Published in Genet Test on January 01, 2005
Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology (2008) 1.69
Association of MUTYH and colorectal cancer. Br J Cancer (2006) 1.42
Chemical and biological consequences of oxidatively damaged guanine in DNA. Free Radic Res (2012) 1.19
Colorectal cancer risk in monoallelic carriers of MYH variants. Am J Hum Genet (2006) 1.13
A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer (2010) 1.11
MUTYH Associated Polyposis (MAP). Curr Genomics (2008) 1.06
Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q. BMC Cancer (2008) 0.99
Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis. Fam Cancer (2011) 0.97
Recently identified colon cancer predispositions: MYH and MSH6 mutations. Semin Oncol (2007) 0.94
Frequency of the common germline MUTYH mutations p.G396D and p.Y179C in patients diagnosed with colorectal cancer in Southern Brazil. Int J Colorectal Dis (2011) 0.86
MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events. Eur J Hum Genet (2013) 0.81
Base excision repair and the role of MUTYH. Hered Cancer Clin Pract (2007) 0.77
Association of monoallelic MUTYH mutation among Egyptian patients with colorectal cancer. Fam Cancer (2017) 0.75
Increased risk for colorectal adenomas and cancer in mono-allelic MUTYH mutation carriers: results from a cohort of North-African Jews. Fam Cancer (2015) 0.75
Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature (1994) 8.04
Prediction of the risk of hereditary retinoblastoma, using DNA polymorphisms within the retinoblastoma gene. N Engl J Med (1988) 3.90
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing. J Med Genet (2004) 2.75
Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet (1993) 2.37
The Swedish rectal cancer registry. Br J Surg (2007) 2.20
Rectal washout and local recurrence of cancer after anterior resection. Br J Surg (2010) 2.16
Randomised controlled trial of a reduced-visits programme of antenatal care in Harare, Zimbabwe. Lancet (1996) 2.15
Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat (1997) 1.88
The risk of medical complications after female circumcision. East Afr Med J (1992) 1.86
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci U S A (2001) 1.80
A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers. Genes Chromosomes Cancer (1998) 1.79
Pre-pregnancy risk factors of small-for-gestational age births among parous women in Scandinavia. Acta Obstet Gynecol Scand (1993) 1.63
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome. Bone Marrow Transplant (2010) 1.59
Distinct and overlapping ligand specificities of the alpha 3A beta 1 and alpha 6A beta 1 integrins: recognition of laminin isoforms. Mol Biol Cell (1994) 1.56
Partogram use in the Dar es Salaam perinatal care study. Int J Gynaecol Obstet (2007) 1.51
Dilemmas and paradoxes in providing and changing antenatal care: a study of nurses and midwives in rural Zimbabwe. Health Policy Plan (2005) 1.45
Operational factors affecting maternal mortality in Tanzania. Health Policy Plan (1997) 1.44
Colorectal cancer with and without microsatellite instability involves different genes. Genes Chromosomes Cancer (1999) 1.44
[When the security requirements are fulfilled. Early discharge as an alternative to care at maternity wards]. Lakartidningen (1994) 1.40
Intrapartum death of nonmalformed fetuses in Denmark and Sweden in 1991. A perinatal audit. Acta Obstet Gynecol Scand (1997) 1.38
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. Fam Cancer (2009) 1.38
Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut (2002) 1.38
Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor. Br J Cancer (1999) 1.36
Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. Carcinogenesis (2001) 1.36
High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer (1995) 1.34
A hospital study of the complications of female circumcision. Trop Doct (1991) 1.33
Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors. BMC Physiol (2001) 1.32
Association studies on 11 published colorectal cancer risk loci. Br J Cancer (2010) 1.31
Microvascular pericytes express platelet-derived growth factor-beta receptors in human healing wounds and colorectal adenocarcinoma. Am J Pathol (1993) 1.31
A rare CYP19 (aromatase) variant may increase the risk of breast cancer. Pharmacogenetics (1998) 1.30
A community-based investigation of avoidable factors for maternal mortality in Zimbabwe. Stud Fam Plann (1997) 1.29
Effectiveness of primary level antenatal care in decreasing anemia at term in Tanzania. Acta Obstet Gynecol Scand (1999) 1.29
Who continues to smoke while pregnant? J Epidemiol Community Health (1992) 1.29
Results from a large multinational clinical trial (guardian™1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A: safety and efficacy. Haemophilia (2013) 1.27
Maternal smoking affects fetal growth more in the male fetus. Paediatr Perinat Epidemiol (2000) 1.26
Maternal morbidity and mortality associated with multiple gestations. Obstet Gynecol (2000) 1.24
Anastomotic leakage after surgery for rectal cancer: a risk factor for local recurrence, distant metastasis and reduced cancer-specific survival? Colorectal Dis (2011) 1.20
Prognostic value of p53 genetic changes in colorectal cancer. J Clin Oncol (1999) 1.20
The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. Cancer Res (2001) 1.20
Microsatellite Instability and hMLH1 and hMSH2 expression analysis in familial and sporadic colorectal cancer. Lab Invest (2001) 1.19
Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J Med Genet (2006) 1.18
Are lymph node micrometastases of any clinical significance in Dukes Stages A and B colorectal cancer? Dis Colon Rectum (1998) 1.17
Female circumcision in Somalia and women's motives. Acta Obstet Gynecol Scand (1991) 1.17
Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families. Cancer Res (1995) 1.17
Eclampsia in Sweden, 1976-1980. Acta Obstet Gynecol Scand (1986) 1.17
Anticholinergic medication in diagnostic endoscopy of the upper gastrointestinal tract. Endoscopy (1991) 1.16
Hyperplastic polyposis coli syndrome and colorectal carcinoma. Endoscopy (2006) 1.16
Staffing needs for quality perinatal care in Tanzania. Afr J Reprod Health (2008) 1.16
Smoking, maternal age, and fetal growth. Obstet Gynecol (1985) 1.14
Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1. Genet Test (1999) 1.14
The role of ataxia-telangiectasia heterozygotes in familial breast cancer. Cancer Res (1998) 1.14
The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer (2001) 1.13
Different occurrence of CD8+, CD45R0+, and CD68+ immune cells in regional lymph node metastases from colorectal cancer as potential prognostic predictors. Int J Colorectal Dis (2002) 1.13
Anaemia in women of reproductive age in Dar-es-Salaam, Tanzania. East Afr Med J (2002) 1.12
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. Cancer Res (1998) 1.12
A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer (2010) 1.11
A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome. J Med Genet (2008) 1.11
Results from a large multinational clinical trial (guardian™3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety, efficacy and pharmacokinetics. Haemophilia (2013) 1.11
Randomised controlled trial of two antenatal care models in rural Zimbabwe. BJOG (2007) 1.10
Unplanned pregnancies in Harare: what are the social and sexual determinants? Soc Sci Med (1997) 1.10
COL11A1 in FAP polyps and in sporadic colorectal tumors. BMC Cancer (2001) 1.10
A study of the PTEN/MMAC1 gene in 136 breast cancer families. Hum Genet (1998) 1.10
High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer. J Med Genet (2005) 1.10
Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms. J Clin Invest (1992) 1.10
Maternal mortality in rural and urban Zimbabwe: social and reproductive factors in an incident case-referent study. Soc Sci Med (1993) 1.09
ATM mutations in cancer families. Cancer Res (1996) 1.09
Oral sedation for diagnostic upper endoscopy. Endoscopy (1991) 1.08
MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer. Cancer Res (2001) 1.06
Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer. Hum Genet (1997) 1.06
Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut (2003) 1.06
Virtual reality colonoscopy simulation: a compulsory practice for the future colonoscopist? Endoscopy (2005) 1.05
Symptoms across pregnancy in relation to psychosocial and biomedical factors. Acta Obstet Gynecol Scand (2001) 1.05
Increased frequency of sister chromatid exchanges in cigarette smokers. Hereditas (1978) 1.04
A germline E-cadherin mutation in a family with gastric and colon cancer. Int J Mol Med (2001) 1.04
Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer. Genes Chromosomes Cancer (2000) 1.04
Low frequency of E-cadherin alterations in familial breast cancer. Breast Cancer Res (2001) 1.04
Classification of colorectal polyps: guidelines for the endoscopist. Endoscopy (2002) 1.03
Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC. J Med Genet (2004) 1.03
Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival. Clin Cancer Res (2000) 1.03
Effect of a new antenatal care programme on the attitudes of pregnant women and midwives towards antenatal care in Harare. Cent Afr J Med (1997) 1.02
Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma. Int J Cancer (2000) 1.01
Loss of heterozygosity in familial breast carcinomas. Cancer Res (1993) 1.00
Detailed physical map of human chromosomal region 11q12-13 shows high meiotic recombination rate around the MEN1 locus. Proc Natl Acad Sci U S A (1991) 1.00
Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Anticancer Res (2000) 1.00
Ki-ras mutations and prognosis in colorectal cancer. Eur J Cancer (1998) 0.99
Hereditary breast cancer: a review. Semin Cancer Biol (2000) 0.99
The complexity of pregnancy anemia in Dar-es-Salaam. Gynecol Obstet Invest (1999) 0.99
Missense mutations in hMLH1 associated with colorectal cancer. Hum Genet (1999) 0.97